Safety reporting proposed reg
This article was originally published in The Tan Sheet
Executive Summary
FDA will accept comments until Oct. 14 on its proposed rule amending premarketing and postmarketing safety reporting requirements for drugs. Original comment deadline for the reg was July 14, but agency received a request for a 90-day extension, which it deems "appropriate, given the length and complexity of the proposed rule." The 1safety reporting proposed rule, which would encourage more reporting of foreign safety data and premarketing adverse events, was published March 14 (2"The Tan Sheet" March 24, 2003, p. 12)...
You may also be interested in...
FDA Drug Safety Rule Would Promote Preclinical Adverse Event Reports
FDA's proposed definition of "suspected adverse drug reactions" would encourage more preclinical adverse event reporting
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.